SS Innovations International (NASDAQ:SSII) and Nyxoah (NASDAQ:NYXH) Head to Head Survey
by Tristan Rich · The Markets DailyNyxoah (NASDAQ:NYXH – Get Free Report) and SS Innovations International (NASDAQ:SSII – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and valuation.
Profitability
This table compares Nyxoah and SS Innovations International’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nyxoah | -443.16% | -178.90% | -81.83% |
| SS Innovations International | -23.73% | -26.77% | -15.01% |
Volatility and Risk
Nyxoah has a beta of 1.63, indicating that its stock price is 63% more volatile than the S&P 500. Comparatively, SS Innovations International has a beta of -1.94, indicating that its stock price is 294% less volatile than the S&P 500.
Valuation and Earnings
This table compares Nyxoah and SS Innovations International”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nyxoah | $11.33 million | 5.27 | -$101.92 million | ($2.52) | -0.61 |
| SS Innovations International | $42.49 million | 15.61 | -$12.13 million | ($0.06) | -55.17 |
SS Innovations International has higher revenue and earnings than Nyxoah. SS Innovations International is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of current ratings for Nyxoah and SS Innovations International, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nyxoah | 1 | 1 | 2 | 0 | 2.25 |
| SS Innovations International | 1 | 0 | 0 | 0 | 1.00 |
Nyxoah presently has a consensus target price of $4.26, indicating a potential upside of 176.75%. SS Innovations International has a consensus target price of $7.00, indicating a potential upside of 111.48%. Given Nyxoah’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Nyxoah is more favorable than SS Innovations International.
Summary
SS Innovations International beats Nyxoah on 7 of the 12 factors compared between the two stocks.
About Nyxoah
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
About SS Innovations International
AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.